相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Intravenous Peramivir for Treatment of Influenza A and B Virus Infection in High-Risk Patients
Shigeru Kohno et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
Phase III Randomized, Double-Blind Study Comparing Single-Dose Intravenous Peramivir with Oral Oseltamivir in Patients with Seasonal Influenza Virus Infection
Shigeru Kohno et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2011)
A single intramuscular injection of neuraminidase inhibitor peramivir demonstrates antiviral activity against novel pandemic A/California/04/2009 (H1N1) influenza virus infection in mice
Shanta Bantia et al.
ANTIVIRAL RESEARCH (2011)
Characterization of the binding affinities of peramivir and oseltamivir carboxylate to the neuraminidase enzyme
Shanta Bantia et al.
ANTIVIRAL RESEARCH (2011)
Systematic review of influenza resistance to the neuraminidase inhibitors
Kristian Thorlund et al.
BMC INFECTIOUS DISEASES (2011)
Estimating the Burden of 2009 Pandemic Influenza A (H1N1) in the United States (April 2009-April 2010)
Sundar S. Shrestha et al.
CLINICAL INFECTIOUS DISEASES (2011)
Peramivir: Another Tool for Influenza Treatment?
Seema Jain et al.
CLINICAL INFECTIOUS DISEASES (2011)
Clinical Experience in Adults and Children Treated with Intravenous Peramivir for 2009 Influenza A (H1N1) Under an Emergency IND Program in the United States
Jaime E. Hernandez et al.
CLINICAL INFECTIOUS DISEASES (2011)
The Emergency Use Authorization of Peramivir IV: A View from the Manufacturer
A. S. Hollister et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2011)
Influenza pharmacotherapy: present situation, strategies and hopes
Paolo Preziosi
EXPERT OPINION ON PHARMACOTHERAPY (2011)
Antiviral Drugs Underused in US Patients for 2009 Influenza A(H1N1) Pandemic
Bridget M. Kuehn
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Use of Intravenous Neuraminidase Inhibitors During the 2009 Pandemic: Results From Population-Based Surveillance
Alicia M. Fry et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2011)
Generation and Characterization of Recombinant Pandemic Influenza A(H1N1) Viruses Resistant to Neuraminidase Inhibitors
Andres Pizzorno et al.
JOURNAL OF INFECTIOUS DISEASES (2011)
Postpartum Pharmacokinetics of Peramivir in the Treatment of 2009 H1N1 Influenza
Patrick G. Clay et al.
OBSTETRICS AND GYNECOLOGY (2011)
Successful salvage therapy with inhaled zanamivir in a patient with peramivir-resistant pandemic influenza A (H1N1) 2009 virus
Ki-Ho Park et al.
SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES (2011)
Peramivir: An Intravenous Neuraminidase Inhibitor for the Treatment of 2009 H1N1 Influenza
Carissa E. Mancuso et al.
ANNALS OF PHARMACOTHERAPY (2010)
Prophylactic Activity of Intramuscular Peramivir in Mice Infected with a Recombinant Influenza A/WSN/33 (H1N1) Virus Containing the H274Y Neuraminidase Mutation
Yacine Abed et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Efficacy and Safety of Intravenous Peramivir for Treatment of Seasonal Influenza Virus Infection
Shigeru Kohno et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Assessment of Pandemic and Seasonal Influenza A (H1N1) Virus Susceptibility to Neuraminidase Inhibitors in Three Enzyme Activity Inhibition Assays
Ha T. Nguyen et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2010)
Combinations of oseltamivir and peramivir for the treatment of influenza A (H1N1) virus infections in cell culture and in mice
Donald F. Smee et al.
ANTIVIRAL RESEARCH (2010)
Host cell selection of influenza neuraminidase variants: Implications for drug resistance monitoring in A(H1N1) viruses
Margaret Okomo-Adhiambo et al.
ANTIVIRAL RESEARCH (2010)
Comprehensive assessment of 2009 pandemic influenza A (H1N1) virus drug susceptibility in vitro
Larisa V. Gubareva et al.
ANTIVIRAL THERAPY (2010)
Correlates of severe disease in patients with 2009 pandemic influenza (H1N1) virus infection
Ryan Zarychanski et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2010)
Rapid Selection of Oseltamivir- and Peramivir-Resistant Pandemic H1N1 Virus during Therapy in 2 Immunocompromised Hosts
Matthew J. Memoli et al.
CLINICAL INFECTIOUS DISEASES (2010)
Intravenous Zanamivir for Patients with Pneumonitis due to Pandemic (H1N1) 2009 Influenza Virus
Georg Haerter et al.
CLINICAL INFECTIOUS DISEASES (2010)
Pandemic Influenza's 500th Anniversary
David M. Morens et al.
CLINICAL INFECTIOUS DISEASES (2010)
Use of Intravenous Zanamivir after Development of Oseltamivir Resistance in a Critically Ill Immunosuppressed Child Infected with 2009 Pandemic Influenza A (H1N1) Virus
Daniel E. Dulek et al.
CLINICAL INFECTIOUS DISEASES (2010)
The Role of Clinical Pharmacology in Supporting the Emergency Use Authorization of an Unapproved Anti-Influenza Drug, Peramivir
V. Arya et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2010)
Drugs in Development for Influenza
David A. Boltz et al.
DRUGS (2010)
Peramivir clearance in continuous renal replacement therapy
Bernadette Thomas et al.
HEMODIALYSIS INTERNATIONAL (2010)
Critically ill infants and children with influenza A (H1N1) in pediatric intensive care units in Argentina
Julio A. Farias et al.
INTENSIVE CARE MEDICINE (2010)
Pandemic (H1N1) 2009-Associated ARDS Rescued by Neuraminidase Inhibitors with Emergency Use of Extracorporeal Membrane Oxygenation
Hideyuki Nakanishi et al.
INTERNAL MEDICINE (2010)
Losing the Opportunity to Study Influenza Drugs
Andrea Meyerhoff et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Pandemic 2009 Influenza A(H1N1) Virus Illness Among Pregnant Women in the United States
Alicia M. Siston et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2010)
Targeting pandemic influenza: a primer on influenza antivirals and drug resistance
Ronald B. Moss et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Detection of Oseltamivir Resistance during Treatment of 2009 H1N1 Influenza Virus Infection in Immunocompromised Patients: Utility of Cycle Threshold Values of Qualitative Real-Time Reverse Transcriptase PCR
Tejal Mehta et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2010)
Severe, critical and fatal cases of 2009 H1N1 influenza in China
Peng Yang et al.
JOURNAL OF INFECTION (2010)
Complexity in Influenza Virus Targeted Drug Design: Interaction with Human Sialidases
Leonard M. G. Chavas et al.
JOURNAL OF MEDICINAL CHEMISTRY (2010)
Outcomes from pandemic influenza A H1N1 infection in recipients of solid-organ transplants: a multicentre cohort study
Deepali Kumar et al.
LANCET INFECTIOUS DISEASES (2010)
Clinical Aspects of Pandemic 2009 Influenza A (H1N1) Virus Infection
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Severe 2009 H1N1 Influenza in Pregnant and Postpartum Women in California
Janice K. Louie et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
CURRENT CONCEPTS Influenza Vaccines for the Future
Linda C. Lambert et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Intravenous Zanamivir for Oseltamivir-Resistant 2009 H1N1 Influenza
Aditya H. Gaur et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Triple Combination of Amantadine, Ribavirin, and Oseltamivir Is Highly Active and Synergistic against Drug Resistant Influenza Virus Strains In Vitro
Jack T. Nguyen et al.
PLOS ONE (2010)
Peramivir Pharmacokinetics in Two Critically Ill Adults with 2009 H1N1 Influenza A Concurrently Receiving Continuous Renal Replacement Therapy
Jose A. Bazan et al.
PHARMACOTHERAPY (2010)
Outcomes of adults hospitalised with severe influenza
N. Lee et al.
THORAX (2010)
Early emergence of an H275Y mutation in a hematopoietic cell transplant recipient treated with intravenous peramivir
C. Renaud et al.
TRANSPLANT INFECTIOUS DISEASE (2010)
Efficacy of Oseltamivir-Zanamivir Combination Compared to Each Monotherapy for Seasonal Influenza: A Randomized Placebo-Controlled Trial
Xavier Duval et al.
PLOS MEDICINE (2010)
Oseltamivir-Resistant Pandemic A/H1N1 Virus Is as Virulent as Its Wild-Type Counterpart in Mice and Ferrets
Marie-Eve Hamelin et al.
PLOS PATHOGENS (2010)
Effectiveness of oseltamivir on disease progression and viral RNA shedding in patients with mild pandemic 2009 influenza A H1N1: opportunistic retrospective study of medical charts in China
Hongjie Yu et al.
BMJ-BRITISH MEDICAL JOURNAL (2010)
PERAMIVIR AND ITS USE IN H1N1 INFLUENZA
R. Castillo et al.
DRUGS OF TODAY (2010)
In Vitro Generation of Neuraminidase Inhibitor Resistance in A(H5N1) Influenza Viruses
Aeron C. Hurt et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Emergence and spread of oseltamivir-resistant A(H1N1) influenza viruses in Oceania, South East Asia and South Africa
Aeron C. Hurt et al.
ANTIVIRAL RESEARCH (2009)
The Influenza Virus Enigma
Rachelle Salomon et al.
CELL (2009)
Developing New Antiviral Agents for Influenza Treatment: What Does the Future Hold?
Frederick Hayden
CLINICAL INFECTIOUS DISEASES (2009)
Seasonal Influenza in Adults and Children-Diagnosis, Treatment, Chemoprophylaxis, and Institutional Outbreak Management: Clinical Practice Guidelines of the Infectious Diseases Society of America
Scott A. Harper et al.
CLINICAL INFECTIOUS DISEASES (2009)
Oseltamivir for treatment and prophylaxis of influenza infection
Patricia Schirmer et al.
EXPERT OPINION ON DRUG SAFETY (2009)
Critically Ill Patients With 2009 Influenza A(H1N1) Infection in Canada
Anand Kumar et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Factors Associated With Death or Hospitalization Due to Pandemic 2009 Influenza A(H1N1) Infection in California
Janice K. Louie et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2009)
Zanamivir-Resistant Influenza Viruses with a Novel Neuraminidase Mutation
Aeron C. Hurt et al.
JOURNAL OF VIROLOGY (2009)
H1N1 pneumonitis treated with intravenous zanamivir
I. Michael Kidd et al.
LANCET (2009)
Antiviral Treatment for Patients Hospitalized with 2009 Pandemic Influenza A (H1N1)
Tim Uyeki
NEW ENGLAND JOURNAL OF MEDICINE (2009)
The Emergency Use Authorization of Peramivir for Treatment of 2009 H1N1 Influenza
Debra Birnkrant et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Global Transmission of Oseltamivir-Resistant Influenza
Anne Moscona
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Emergence of Oseltamivir-Resistant Pandemic H1N1 Virus during Prophylaxis
Mariana Baz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Hospitalized Patients with 2009 H1N1 Influenza in the United States, April-June 2009.
Seema Jain et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Severe Human Influenza Infections in Thailand: Oseltamivir Treatment and Risk Factors for Fatal Outcome
Wanna Hanshaoworakul et al.
PLOS ONE (2009)
The origin and global emergence of adamantane resistant A/H3N2 influenza viruses
Martha I. Nelson et al.
VIROLOGY (2009)
Intramuscularly administered neuraminidase inhibitor peramivir is effective against lethal H5N1 influenza virus in mice
David A. Boltz et al.
ANTIVIRAL RESEARCH (2008)
Current and future antiviral therapy of severe seasonal and avian influenza
John Beigel et al.
ANTIVIRAL RESEARCH (2008)
Injectable peramivir mitigates disease and promotes survival in ferrets and mice infected with the highly virulent influenza virus, A/Vietnam/1203/04 (H5N1)
Nadezhda E. Yun et al.
VIROLOGY (2008)
Antiviral therapy and outcomes of influenza requiring hospitalization in Ontario, Canada
Allison McGeer et al.
CLINICAL INFECTIOUS DISEASES (2007)
Characterization of drug-resistant recombinant influenza A/H1N1 viruses selected in vitro with peramivir and zanamivir
Mariana Baz et al.
ANTIVIRAL RESEARCH (2007)
Evaluation of methyl inosine monophosphate (MIMP) and peramivir activities in a murine model of lethal influenza A virus infection
Vasihy P. Mishin et al.
ANTIVIRAL RESEARCH (2006)
Combination chemotherapy, a potential strategy for reducing the emergence of drug-resistant influenza A variants
Natalia A. Ilyushina et al.
ANTIVIRAL RESEARCH (2006)
Anti-influenza virus activity of peramivir in mice with single intramuscular injection
S Bantia et al.
ANTIVIRAL RESEARCH (2006)
A review of vaccine research and development: Human acute respiratory infections
MP Girard et al.
VACCINE (2005)
Drug therapy - Neuraminidase inhibitors for influenza
A Moscona
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Virulence may determine the necessary duration and dosage of oseltamivir treatment for highly pathogenic A/Vietnam/1203/04 influenza virus in mice
HL Yen et al.
JOURNAL OF INFECTIOUS DISEASES (2005)
Comparison of the anti-influenza virus activity of cyclopentane derivatives with oseltamivir and zanamivir in vivo
P Chand et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2005)
Neuraminidase is important for the initiation of influenza virus infection in human airway epithelium
MN Matrosovich et al.
JOURNAL OF VIROLOGY (2004)
Stereoselective total synthesis of racemic BCX-1812 (RWJ-270201) for the development of neuraminidase inhibitors as anti-influenza agents
T Mineno et al.
JOURNAL OF ORGANIC CHEMISTRY (2003)
Prolonged shedding of multidrug-resistant influenza A virus in an immunocompromised patient
DM Weinstock et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Safety and pharmacology of oseltamivir in clinical use
R Dutkowski et al.
DRUG SAFETY (2003)
Mechanism by which mutations at His274 alter sensitivity of influenza a virus N1 neuraminidase to oseltamivir carboxylate and zanamivir
MZ Wang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Susceptibility of recent Canadian influenza A and B virus isolates to different neuraminidase inhibitors
G Boivin et al.
ANTIVIRAL RESEARCH (2002)
Oral administration of cyclopentane neuraminidase inhibitors protects ferrets against influenza virus infection
C Sweet et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Comparison of the activities of zanamivir, oseltamivir, and RWJ-270201 against clinical isolates of influenza virus and neuraminidase inhibitor-resistant variants
LV Gubareva et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Comparison of efficacies of RWJ-270201, zanamivir, and oseltamivir against H5N1, H9N2, and other avian influenza viruses
EA Govorkova et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Primary immune system effects of the orally administered cyclopentane neuraminidase inhibitor RWJ-270201 in influenza virus-infected mice
RW Sidwell et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2001)
Comparison of the anti-influenza virus activity of RWJ-270201 with those of oseltamivir and zanamivir
S Bantia et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Cyclopentane neuraminidase inhibitors with potent in vitro anti-influenza virus activities
DF Smee et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
In vivo influenza virus-inhibitory effects of the cyclopentane neuraminidase inhibitor RWJ-270201
RW Sidwell et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2001)
Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir
LV Gubareva et al.
JOURNAL OF INFECTIOUS DISEASES (2001)
In vitro and in vivo assay systems for study of influenza virus inhibitors
RW Sidwell et al.
ANTIVIRAL RESEARCH (2000)
BCX-1812 (RWJ-270201): Discovery of a novel, highly potent, orally active, and selective influenza neuraminidase inhibitor through structure-based drug design
YS Babu et al.
JOURNAL OF MEDICINAL CHEMISTRY (2000)
Efficacy and safety of the oral neuraminidase inhibitor oseltamivir in treating acute influenza - A randomized controlled trial
JJ Treanor et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
分享论文
